The new prime DX® technology for molecular tumor profiling is compatible with both FFPE and PLASMA!
HerediGENE®
HerediGENE® is a diagnostic multi-gene test for hereditary cancer, which analyses 52 genes, including BRCA1 and BRCA2, which are involved in the increased risk of breast, ovarian, prostate, colorectal and other hereditary cancers.
Com.pl.i.t DX®
Com.Pl.i.t. DX Assay is a multigene test designed to help you and your physician make informed treatment decisions based on the unique biology of your tumor and individualize your treatment.
The Molecular Biology and Precision Medicine Elearning Platform
Our journey began in 2007 and we are constantly growing, to provide the highest quality services in the Molecular diagnostics sector, specializing in oncology, cardiology, neurology, and pharmacogenomics.
A passionate team sharing the same vision of quality healthcare is working together to deliver to physicians and patients actionable information for the decision-making process.
We aim to individualize the journey of patients from diagnosis to treatment response and selection and to reveal their genetic predisposition to Hereditary Syndromes.
Genekor is actively establishing its international presence by expanding all over the world with the ultimate goal of revolutionizing treatment by incorporating up-to-date technologies and assays in everyday clinical practice.
In this platform, you will be able to learn and test yourself on molecular biology and its value to the practice of precision medicine from scientists and doctors worldwide.
Why It Matters:
Investing in our learning and development is crucial for
staying competitive and fostering innovation within our team. This platform is
a valuable resource to help you stay updated with the latest industry trends
and advance your knowledge and professional development.